相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Reduced α-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype
Hassan O. A. Elsaid et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2022)
Establishment and Characterization of MUi027-A: A Novel Patient-Derived Cell Line of Polycystic Kidney Disease with PKD1 Mutation
Aung Khine Linn et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
The genetic spectrum of Gitelman(-like) syndromes
Karl P. Schlingmann et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2022)
Determining epigenetic memory in kidney proximal tubule cell derived induced pluripotent stem cells using a quadruple transgenic reprogrammable mouse
Gabriel Khelifi et al.
SCIENTIFIC REPORTS (2022)
Human kidney organoids reveal the role of glutathione in Fabry disease
Jin Won Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians
Laura Nunez-Gonzalez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Human-induced pluripotent stem cell lines (CMCi006-A and CMCi007-A) from a female and male patient with Fabry disease carrying the same frameshift deletion mutation
Sheng Cui et al.
STEM CELL RESEARCH (2021)
DNA methylation impact on Fabry disease
Teodolinda Di Risi et al.
CLINICAL EPIGENETICS (2021)
Fabry nephropathy before and after enzyme replacement therapy: important role of renal biopsy in patients with Fabry disease
Il Young Kim et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2021)
Modeling of endothelial cell dysfunction using human induced pluripotent stem cells derived from patients with end-stage renal disease
Kyoung Woon Kim et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2021)
Fabry disease exacerbates renal interstitial fibrosis after unilateral ureteral obstruction via impaired autophagy and enhanced apoptosis
Sungjin Chung et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2021)
Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte Loss
Behzad Najafian et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Generation of a human induced pluripotent stem cell line (CMCi002-A) from a patient with Gitelman's syndrome
Sun Woo Lim et al.
STEM CELL RESEARCH (2020)
Newborn screening for Fabry disease in the western region of Japan
Takaaki Sawada et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2020)
α-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease
Justin J. Kang et al.
KIDNEY INTERNATIONAL (2019)
CRISPR Gene Editing in the Kidney
Nelly M. Cruz et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Fabry disease in the Spanish population: observational study with detection of 77 patients
Irene Vieitez et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Generation of Fabry cardiomyopathy model for drug screening using induced pluripotent stem cell-derived cardiomyocytes from a female Fabry patient
Yuki Kuramoto et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Organoids from Nephrotic Disease-Derived iPSCs Identify Impaired NEPHRIN Localization and Slit Diaphragm Formation in Kidney Podocytes
Shunsuke Tanigawa et al.
STEM CELL REPORTS (2018)
Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease
Nelly M. Cruz et al.
NATURE MATERIALS (2017)
Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report
Yosep Chong et al.
BMC MEDICAL GENETICS (2016)
GLA variation p.E66Q identified as the genetic etiology of Fabry disease using exome sequencing
Hao Peng et al.
GENE (2016)
Molecular and clinical studies in five index cases with novel mutations in the GLA gene
Carmela Zizzo et al.
GENE (2016)
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
Alberto Ortiz et al.
JOURNAL OF MEDICAL GENETICS (2016)
Identification of mutations in Colombian patients affected with Fabry disease
Alfredo Uribe et al.
GENE (2015)
Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids
Benjamin S. Freedman et al.
NATURE COMMUNICATIONS (2015)
Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy using Human Induced Pluripotent Stem Cells
Faye M. Drawnel et al.
CELL REPORTS (2014)
Plasma mutant alpha-galactosidase A protein and globotriaosylsphingosine level in Fabry disease
Takahiro Tsukimura et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2014)
A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis
Atsumi Taguchi et al.
BIOCHEMICAL JOURNAL (2013)
Applications of Patient-Specific Induced Pluripotent Stem Cells; Focused on Disease Modeling, Drug Screening and Therapeutic Potentials for Liver Disease
Yong Soon Chun et al.
International Journal of Biological Sciences (2012)
Possible role of transforming growth factor-β1 and vascular endothelial growth factor in Fabry disease nephropathy
Mi Hee Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Identification of a Novel Mutation and Prevalence Study for Fabry Disease in Japanese Dialysis Patients
Tomoya Nishino et al.
RENAL FAILURE (2012)
Epigenetic Memory and Preferential Lineage-Specific Differentiation in Induced Pluripotent Stem Cells Derived from Human Pancreatic Islet Beta Cells
Ori Bar-Nur et al.
CELL STEM CELL (2011)
Induced pluripotent stem cells - opportunities for disease modelling and drug discovery
Marica Grskovic et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The Human Gene Mutation Database: 2008 update
Peter D. Stenson et al.
GENOME MEDICINE (2009)
Lysosomal storage disease 3 - Fabry's disease
Yuri A. Zarate et al.
LANCET (2008)
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Johannes M. Aerts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer
J Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)